1. Home
  2. BCYC vs GTN Comparison

BCYC vs GTN Comparison

Compare BCYC & GTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • GTN
  • Stock Information
  • Founded
  • BCYC 2009
  • GTN 1897
  • Country
  • BCYC United Kingdom
  • GTN United States
  • Employees
  • BCYC N/A
  • GTN N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • GTN Broadcasting
  • Sector
  • BCYC Health Care
  • GTN Industrials
  • Exchange
  • BCYC Nasdaq
  • GTN Nasdaq
  • Market Cap
  • BCYC 565.5M
  • GTN 523.7M
  • IPO Year
  • BCYC 2019
  • GTN N/A
  • Fundamental
  • Price
  • BCYC $8.18
  • GTN $4.40
  • Analyst Decision
  • BCYC Buy
  • GTN Strong Buy
  • Analyst Count
  • BCYC 11
  • GTN 4
  • Target Price
  • BCYC $22.91
  • GTN $6.88
  • AVG Volume (30 Days)
  • BCYC 284.7K
  • GTN 939.6K
  • Earning Date
  • BCYC 10-31-2025
  • GTN 11-07-2025
  • Dividend Yield
  • BCYC N/A
  • GTN 7.27%
  • EPS Growth
  • BCYC N/A
  • GTN 1482.23
  • EPS
  • BCYC N/A
  • GTN 1.53
  • Revenue
  • BCYC $19,281,000.00
  • GTN $3,549,000,000.00
  • Revenue This Year
  • BCYC N/A
  • GTN N/A
  • Revenue Next Year
  • BCYC N/A
  • GTN $13.18
  • P/E Ratio
  • BCYC N/A
  • GTN $2.87
  • Revenue Growth
  • BCYC N/A
  • GTN 7.03
  • 52 Week Low
  • BCYC $6.10
  • GTN $2.91
  • 52 Week High
  • BCYC $25.39
  • GTN $6.31
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 53.38
  • GTN 28.87
  • Support Level
  • BCYC $7.65
  • GTN $4.76
  • Resistance Level
  • BCYC $8.42
  • GTN $4.93
  • Average True Range (ATR)
  • BCYC 0.49
  • GTN 0.22
  • MACD
  • BCYC -0.05
  • GTN -0.03
  • Stochastic Oscillator
  • BCYC 40.38
  • GTN 8.86

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About GTN Gray Television Inc.

Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios.

Share on Social Networks: